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Tuesday, February 23, 2010 511apotassium channel KcsA as the template, encompasses transmembrane helices
8-10 and provides an excellent description for the pore domain of RyR2 with
the overall structure and arrangement of key structural elements of the model
closely resembling those of KcsA (Biophysical Journal 2004, 87, 2335-2351).
Although good progress has been made in understanding ion handling capabil-
ities in RyR2 the exact mechanisms remain elusive and controversial. To test
and define the analogy model we have constructed and expressed both the
PFR of RyR2 alone and a KcsA_RyR2_PFR chimera whereby the 22 residue
N-terminal helix and 41 residue C-terminal domain of KcsA have been added
by primer extension to the RyR2 PFR region and cloned into a modified pET
expression vector containing an N-terminal hexa-His tag. Just as voltage sensor
modules are transferable among potassium channels, our chimera will give us
information on the functionality and transferability of the RyR2 PFR. Prelim-
inary results indicate that both the chimera and PFR constructs express in large
amounts in rosetta bacterial cells and are targeted to the membrane with no de-
tectable protein in the soluble fraction. Detergent trials have identified LDAO
as the best candidate for solubilisation from the membrane although other com-
monly used detergents are also capable of solubilisation, albeit to a lesser de-
gree. Both constructs were purified as tetramers following nickel-affinity and
gel filtration chromatography. This suggests strongly that both the RyR2
PFR and chimera are functional proteins capable of tetramerisation.
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Malignant hyperthermia (MH) is a life-threatening pharmacogenetic syndrome
of skeletal muscle associated with mutations in the Ca2þ release channel - rya-
nodine receptor type 1 (RyR1). A genetically engineered knock-in mouse that
expresses the human C-terminal MH mutation T4826I RyR1 was created. Both
RyR1-T4826I/WT (HET) and RyR1-T4826I/T4826I (HOM) mice survive and
thrive if unchallenged with triggering agents. Sarcoplasmic reticulum mem-
branes from HET, HOM, and wild type (WT) mice were prepared to study
the biochemical and biophysical properties of RyR1complexes using [3H]rya-
nodine ([3H]Ry) binding analysis, western blotting, and single channels incor-
porated in bilayer lipid membranes. The results from this study reveal: (1) Sig-
nificantly elevated [3H]Ry binding in the preparations with rank order HOM
>>HET>WT), (2) significant diminution in the inhibitory potency of Ca2þ
and Mg2þ for both HOM and HET, (3) initial rates of [3H]Ry binding with
rank order HOM>>HET>WTwhen measured at either 25 C or 37C, (4) Sig-
nificantly greater open probability, longer mean open dwelling time and shorter
mean closed times with HOM and HET channels. These data indicate that the
T4826I RyR1 mutation confers significantly destabilizes the closed channel
conformation of RyR1, and the altered channel properties may be mostly re-
sponsible for the abnormal intracellular Ca2þ homeostasis and the MH suscep-
tibility. (Words: 202).
2647-Pos
AICAR Prevents Heat-Induced Death in Mice with Malignant Hyper-
thermia
Johanna T. Lanner, Cheng Long, JianJun Xu, Mariah R. Baker,
Susan L. Hamilton.
Baylor College of Medicine, Houston, TX, USA.
The pharmacogenetic disorder malignant hyperthermia (MH) is serious and po-
tentially life-threatening illness caused by mutations in the skeletal muscle
Ca2þ-release channel (ryanodine receptor, RyR1) located in the membrane of
the sarcoplasmic reticulum. An MH episode is triggered by general anesthetics,
heat and exercise in warm conditions. Signs of an MH crisis are: elevated core
temperature, arrhythmias, hyper-metabolism and rhabdomyolysis. The MH
mice created in our laboratory with a Y524Sþ/- mutation in RyR1
(RyR1Y524Sþ/-) die upon exposure to elevated environmental temperatures
(37C) (Chelu et al 2006). The muscle relaxant dantrolene is the only known
treatment for an MH crisis, but its adverse side-effects preclude prophylactic
usage. We find that the treatment of the RyR1Y524Sþ/- mice with 5-aminoimi-
dazole-4-carboxamide ribonucleoside (AICAR), an activator of AMP-activated
protein kinase (AMPK), prevents heat-induced sudden death. Less than 5% of
untreated RyR1Y524Sþ/- mice survive a heat-challenge, but treatment with AI-
CAR leads to 100% survival. Muscle AMPK phosphorylation (AMPKaThr172)
levels are not significantly altered after 10 min subcutaneous injection with AI-
CAR compared to saline. This suggests that the rescue may not be due solely toAMPK activation, but may also involve off-target effect(s) of AICAR. Adenine
nucleotides are known channel agonists and AICAR is a precursor of the AMP
analog, ZMP. We tested the effects of AICAR on 3H -ryanodine binding in the
presence of non-hydrolysable ATP (AMP-PCP). We find that AICAR is a par-
tial agonist of RyR1 and prevents full activation of RyR1 in the presence of cel-
lular concentrations of ATP in both RyR1Y524Sþ/- and wild-type mice. AICAR
prevents heat-induced death in mice with MH and, since it is thought to have
few side-effects, it is a potential prophylactic treatment for heat induced death
associated with some MH mutations.
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The devastating consequences of calcium dysregulation are exemplified by
the skeletal muscle diseases malignant hyperthermia (MH) and central core
disease (CCD). These diseases result from mutations in the ‘skeletal muscle-
isoform’ of the ryanodine receptor calcium release channel (RyR1). To inves-
tigate the etiology of MH and CCD, mouse models have recently been
generated (Chelu et al. 2005). Skeletal muscle harboring the Y522S-RyR1
knock-in mutation exhibit Ca2þ leak from internal stores, basal cellular stress,
and ultimately progressive mitochondrial and cellular damage (Durham et al.
2008). Although the effects of this MH-causing mutation have been character-
ized in skeletal muscle, the effects in the nervous system have not been
documented. RyR1 is expressed highly in cerebellar Purkinje neurons.
Y522S-RyR1 mice do not exhibit gross neurological defects suggesting that
the defects may be subtle or that neuronal function is spared due to compen-
satory changes.
We have initiated studies investigating 3 main aspects of Y522S-RyR1 mouse
Purkinje cells: intracellular calcium release, cellular organization/morphology,
and cellular stress. In preliminary studies using imaging techniques with the
calcium indicator dye Fura2-AM, RyR-mediated calcium release in Y522S-
RyR1 Purkinje neurons exhibited a negative shift in the apparent EC50 for
the agonist caffeine. In addition, the sensitivity of RyR to other activators (tem-
perature, voltage, ryanodine) and intracellular calcium store content were in-
vestigated. Since calcium signaling is important during neuronal development
and maturation, the morphology of Y522S-RyR1 Purkinje cells was examined
using immunohistochemistry and confocal microscopy. Moreover, we have ini-
tiated studies to determine if altered RyR1 function results in basal cellular
stress using Western blot and immunohistochemical analyses. Y522S-RyR1
mutant mice provide an excellent tool to address calcium dysregulation, its
pathological consequences, and potential approaches for compensation of al-
tered calcium signaling in the central nervous system.
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The cardiac ryanodine receptor (RyR2) Ca2þ release channel plays a central
role in the rapid calcium release from the sarcoplasmic reticulum that is essen-
tial for muscle excitation-contraction coupling. Discrete mutations that have
been discovered within the RyR2 associated with catecholaminergic polymor-
phic ventricular tachycardia (CPVT) are found to cluster in distinct regions of
RyR2. These regions may represent important regulatory domains of the mol-
ecule that either directly or indirectly can affect channel gating. In response to
a physiological trigger, RyR2 mutations are believed to cause diastolic Ca2þ
leak which results in arrhythmia, making them an important potential therapeu-
tic target.
We have expressed the RyR2 central domain CPVT-associated region and ex-
amined parameters which contribute to the structural and functional stability. A
wild-type construct was compared with three constructs each containing a dif-
ferent CPVT mutation (P2328S, N2368I or A2387P). Circular dichroism spec-
troscopy revealed that none of the mutations significantly altered the percent-
age ellipticity of the protein, indicating that the overall conformation of the
polypeptide backbone is only slightly affected by the mutations. Chemical de-
naturation using guanidine hydrochloride and monitoring tryptophan fluores-
cence suggested that the P2328S mutation was less stable than the wild-type
or the other two mutations, indicated by a lower free energy change upon un-
folding. A predicted ATP binding motif has previously been proposed in this
domain and using fluorescence spectroscopy for the wild-type construct,
ATP binding was observed with a Kd ~0.03mM.
